Jefferies Initiates Coverage of Caris Life Sciences Inc. (CAI) With a Buy Rating [Yahoo! Finance]
Caris Life Sciences, Inc. (CAI)
Last caris life sciences, inc. earnings: 10/29 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.capps.com/investor-relations
Company Research
Source: Yahoo! Finance
Sciences Inc. (NASDAQ:CAI) with a Buy rating on April 13, setting a $28 price target on the stock. The firm told investors that it sees “secular tailwinds” in the oncology diagnostics space from improving therapies and declining sequencing costs. However, it also cited the “ongoing polarization between the leaders and laggards”, adding that the firm views Caris Life Sciences Inc. (NASDAQ:CAI) and Veracyte as “compelling stocks” given their profitability, valuations, and pipelines. In another development, Goldman Sachs initiated coverage of Caris Life Sciences Inc. (NASDAQ:CAI) with a Buy rating and $27 price target on April 1. The firm told investors in a research note that the company can continue to see volume growth within the therapy selection offering, adding that it also believes Caris Life Sciences Inc. (NASDAQ:CAI) holds the potential to unlock additional addressable market opportunities through upcoming launches in its pipeline. Caris Life Sciences Inc. (NASDAQ:CAI) provide
Show less
Read more
Impact Snapshot
Event Time:
CAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAI alerts
High impacting Caris Life Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
CAI
News
- Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026 [TheStreet.com]TheStreet.com
- Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026PR Newswire
- Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center [TheStreet.com]TheStreet.com
- Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer CenterPR Newswire
- Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients [TheStreet.com]TheStreet.com
CAI
Earnings
- 2/26/26 - Beat
CAI
Sec Filings
- 4/7/26 - Form SCHEDULE
- 4/2/26 - Form 8-K
- 3/10/26 - Form 4
- CAI's page on the SEC website